.Permit's dive into a conversation along with Ayla Ellison, Fierce Biotech Managing Editor and Miche...
.Bayer suspended the stage 3 test for its factor XIa prevention asundexian behind time last year aft...
.Sanofi is actually still set on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA,...
.Galapagos is happening under extra stress from investors. Having actually built a 9.9% concern in G...
.Welcome to today's Chutes & Ladders, our summary of significant management hirings, shootings an...
.Shanghai Allist Pharmaceuticals has gotten on its own a starring role in China's KRAS market, payin...
.ReNeuron has joined the lengthy listing of biotechs to leave behind London's intention stock market...
.MBX Biosciences has added to the recent outbreak of IPO filings. The biotech, which filed its own d...
.For Lykos Therapeutics as well as the company's prospective MDMA-assisted treatment for trauma (POS...
.Simply days after genetics publisher Volume Biosciences introduced hidden operational cuts, a clear...